Related Experiment Videos
Seizures and bupropion: a review
1Department of Psychiatry, Duke University Medical Center, Durham, N.C. 27710.
The Journal of Clinical Psychiatry
|July 1, 1989
Summary
Bupropion use is associated with a seizure risk, particularly at higher doses. Healthcare providers should consider patient predisposing factors and adhere to recommended bupropion dosages to minimize seizure occurrence.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Bupropion is an antidepressant medication with a known risk of seizures.
- Understanding the incidence and risk factors for bupropion-associated seizures is crucial for patient safety.
Purpose of the Study:
- To examine the relationship between bupropion use and seizure occurrence.
- To identify risk factors associated with bupropion-induced seizures.
Main Methods:
- Analysis of manufacturer's reports on seizure events linked to bupropion.
- Calculation of seizure incidence and cumulative risk at various bupropion dosages.
Main Results:
- Seizure incidence ranged from 0.35%-0.44% with bupropion doses ≤450 mg/day.
- The cumulative 2-year risk of seizures was 0.48% at the maximum recommended dose.
- Seizure risk increased with bupropion doses exceeding the recommended maximum, with predisposing factors in over half of reported cases.
Conclusions:
- Bupropion use carries a dose-dependent risk of seizures.
- Predisposing factors significantly influence seizure risk in patients taking bupropion.
- Adherence to recommended dosages and careful patient selection are vital for safe bupropion prescribing.